Breast Center, Peking University People's Hospital, Beijing, China.
Int J Med Sci. 2021 Jun 11;18(13):2990-2996. doi: 10.7150/ijms.53812. eCollection 2021.
Bioelectrical impedance technology is a common technique used for the early detection of breast cancer-related lymphedema (BCRL). However, studies on the threshold value established by Inbody 720 device (Biospace, Korea) have been extremely limited. We aimed to determine its reference range and cutoff values. All patients were recruited from October 2017 to October 2019 at the Peking University People's Hospital Breast Center. In total, 82 patients with unilateral BCRL and 1305 healthy subjects were recruited in this study. We measured the extracellular fluid (ECF) ratio, extracellular water (ECW) ratio, as well as the single-frequency bioimpedance analysis (SFBIA) ratios at 1 and 5 kHz with the Inbody 720 device. The Youden index-based cutoff points, mean + 2SD and mean + 3SD values of these four indicators for both dominant and nondominant arms were also calculated. Data were collected from 1387 women, including healthy subjects and patients with lymphedema. All statistical analyses were performed with SPSS. Significant differences were found between the two groups in the ECW, ECF, and SFBIA ratios. For the dominant affected arms, the Youden index-based cutoff points for the ECF, ECW, as well as SFBIA ratios at 1 and 5 kHz were 1.009, 1.008, 1.068, and 1.068, respectively. For the nondominant affected arms, the Youden index-based cutoff points were 1.014, 1.013, 1.047, and 1.048, respectively. The mean + 2 standard deviations (SD) and mean + 3SD values were also calculated. We determined the Youden index-based cutoff points, mean + 2SD and mean + 3SD values of the ECF, ECW, as well as SFBIA ratios at 1 and 5 kHz for both dominant and nondominant arms with data from 1305 healthy subjects. Next, the Youden index-based cutoff points, the mean + 2SD and mean + 3SD values were used to recognize patients with lymphedema. We found that the Youden index-based cutoff points and the mean + 2SD showed similar identification capacity on lymphedema, and they seemed to distinguish more patients with lymphedema than mean + 3SD values.
生物电阻抗技术是一种用于早期检测乳腺癌相关淋巴水肿(BCRL)的常用技术。然而,关于 Inbody 720 设备(Biospace,韩国)建立的阈值的研究极为有限。我们旨在确定其参考范围和截断值。所有患者均于 2017 年 10 月至 2019 年 10 月在北京大学人民医院乳腺中心招募。本研究共纳入 82 例单侧 BCRL 患者和 1305 例健康受试者。我们使用 Inbody 720 设备测量细胞外液(ECF)比、细胞外水(ECW)比以及 1 和 5 kHz 时的单频生物阻抗分析(SFBIA)比。还计算了这四个指标在优势和非优势手臂上的基于 Youden 指数的截断点、均值+2SD 和均值+3SD 值。数据来自 1387 名女性,包括健康受试者和淋巴水肿患者。所有统计分析均使用 SPSS 进行。两组间 ECW、ECF 和 SFBIA 比均存在显著差异。对于优势受累手臂,基于 Youden 指数的 ECF、ECW 以及 1 和 5 kHz 时 SFBIA 比的截断点分别为 1.009、1.008、1.068 和 1.068。对于非优势受累手臂,基于 Youden 指数的截断点分别为 1.014、1.013、1.047 和 1.048。还计算了均值+2 标准差(SD)和均值+3SD 值。我们根据 1305 名健康受试者的数据确定了优势和非优势手臂的 ECF、ECW 以及 1 和 5 kHz 时 SFBIA 比的基于 Youden 指数的截断点、均值+2SD 和均值+3SD 值。然后,使用基于 Youden 指数的截断点、均值+2SD 和均值+3SD 值来识别淋巴水肿患者。我们发现,基于 Youden 指数的截断点和均值+2SD 在识别淋巴水肿方面具有相似的能力,而且它们似乎比均值+3SD 值能区分出更多的淋巴水肿患者。